The aim was to study the effects of zinc (Zn) and fluoride (F) on remineralisation at plaque fluid concentrations. Artificial carious lesions were created in 2 acid-gel demineralising systems (initially infinitely undersaturated and partially saturated with respect to enamel) giving lesions with different mineral distribution characteristics (high and low R values, respectively) but similar integrated mineral loss values. Lesions of both types were assigned to 1 of 4 groups and remineralised for 5 days at 37°C. Zn and F were added, based on plaque fluid concentrations 1 h after application, to give 4 treatments: 231 µmol/l Zn, 10.5 µmol/l F, Zn/F combined and an unmodified control solution (non-F/non-Zn). Subsequently remineralisation was measured using microradiography. High-R lesions were analysed for calcium, phosphorus, F and Zn using electron probe micro-analysis. All lesions underwent statistically significant remineralisation. For low-R lesions, remineralisation was in the order Fa < non-F/non-Zna < Zna, b < Zn/Fb, and for high-R lesions Fa < non-F/non-Znb < Znb < Zn/Fc (treatments with the same superscript letter not significantly different, at p < 0.05). Qualitatively, remineralisation occurred throughout non-F/non-Zn and Zn groups, predominantly at the surface zone (F) and within the lesion body (Zn/F). Electron probe micro-analysis revealed Zn in relatively large amounts in the outer regions (Zn, Zn/F). F was abundant not only at the surface (F), but also in the lesion body (Zn/F). Calcium:phosphate ratios were similar to hydroxyapatite (all). To conclude, under static remineralising conditions simulating plaque fluid, Zn/F treatment gave significantly greater remineralisation than did F treatment, possibly because Zn in the Zn/F group maintained greater surface zone porosity compared with F, facilitating greater lesion body remineralisation.

Keywords:
Fluoride, Remineralisation, Zinc
1.
Afseth J, Helgeland K, Bonesvoll P: Retention of Cu and Zn in the oral cavity following rinsing with aqueous solutions of copper and zinc salts. Scand J Dent Res 1983;91:42–45.
2.
Arends J, Christoffersen J: The nature of early caries lesions in enamel. J Dent Res 1986;65:2–11.
3.
Arends J, Ruben JL, Inaba D: Major topics in quantitative microradiography of enamel and dentin: R parameter, mineral distribution visualization, and hyper-remineralization. Adv Dent Res 1997;11:403–414.
4.
Brudevold F, Steadman LT, Spinelli MA, Amdur BH, Gron P: A study of zinc in human teeth. Arch Oral Biol 1963;8:135–144.
5.
Carey C, Gregory T, Rupp W, Tatevossian A, Vogel GL: The driving forces in human dental plaque-fluid for demineralisation and remineralisation of enamel mineral; in Leach SA (ed): Factors Relating to Demineralisation and Remineralisaation of the Teeth. Oxford, IRL Press, 1986, pp 163–173.
6.
Crabb HSM: Enamel caries: observations on the histology and pattern of progress of the approximal lesion. Br Dent J 1966;121:115, 167.
7.
Driessens FCM, Theuns HM, Heilijgers HJM, Borggreven JM: Microradiography and electron microprobe analysis of some natural white and brown spot enamel lesions with and without laminations. Caries Res 1986;20:398–405.
8.
Ekstrand J: Fluoride in plaque fluid and saliva after NaF or MFP rinses. Eur J Oral Sci 1997;105:478–484.
9.
Featherstone JDB: Dental caries: a dynamic disease process. Aust Dent J 2008;53:286–291.
10.
Featherstone JDB, Rodgers BE, Smith MW: Physicochemical requirements for rapid remineralisation of early carious lesions. Caries Res 1981;15:221–235.
11.
Featherstone JDB, Shields CP, Khademazad B, Oldershaw MD: Acid reactivity of carbonated apatites with strontium and fluoride solutions. J Dent Res 1983;62:1049–1053.
12.
Fujikawa H, Matsuyama K, Uchiyama A, Nakashima S, Ujiie T: Influence of salivary macromolecules and fluoride on enamel lesion remineralization in vitro. Caries Res 2008;42:37–45.
13.
Gao XJ, Fan Y, Kent RL Jr, Van Houte J, Margolis HC: Association of caries activity with the composition of dental plaque fluid. J Dent Res 2001;80:1834–1839.
14.
Gilbert RJ: The oral clearance of zinc and triclosan after delivery from a dentifrice. J Pharm Pharmacol 1987;39:480–483.
15.
Gilbert RJ, Ingram GS: The oral disposition of zinc following the use of an anti-calculus toothpaste containing 0.5% zinc citrate. J Pharm Pharmacol 1988;40:399–402.
16.
Günbay S, Biçakçi N, Parlak H, Güneri T, Kirilmaz L: The effect of zinc chloride dentifrices on plaque-growth and oral zinc levels. Quintessence Int 1992;23:619–624.
17.
Harrap GJ, Best JA, Saxton CA: Human oral retention of zinc from mouthwashes containing zinc salts and its relevance to dental plaque-control. Arch Oral Biol 1984;27:87–91.
18.
Ingram GS, Baker AG, Best JS, Mellor-Chrimes CP: The influence of zinc citrate in a fluoride dentifrice on rat caries and fluoride content of molar enamel in vivo. J Dent Res 1984;63:497.
19.
Ingram GS, Horay CP, Stead WJ: Interaction of zinc with dental mineral. Caries Res 1992;26:248–253.
20.
Kostlan J: Translucent zone in the central part of the carious lesion of enamel. Br Dent J 1962;113:244.
21.
Larsen MJ, Fejerskov O: Chemical and structural challenges in remineralization of dental enamel lesions. Scand J Dent Res 1989;97:285–296.
22.
Larsen MJ: Ion Products and Solubility of Calcium Phosphates. Aarhus, Royal Dental College, 2001.
23.
Laucello M, Noel N, Lynch RJM, Ferro R, Lipscombe C: The anti-caries efficacy of a silica-based fluoride toothpaste containing 0.75% zinc citrate, 0.3% triclosan, vitamin E and sunflower oil. Int Dent J 2007;57(suppl 1): 145–149.
24.
Le Geros RZ, Bleiwas CB, Retino M, Rohanizadeh R, Le Geros JP: Zinc effect on the in vitro formation of calcium phosphates: relevance to clinical inhibition of calculus formation. Am J Dent 1999;12:65–71.
25.
Lippert F, Lynch RJM, Eckert GJ, Kelly SA, Hara AT, Zero DT: In situ fluoride response of caries lesions with different mineral distributions at baseline. Caries Res 2011;45:47–55.
26.
Lynch RJM, Mony U, ten Cate JM: The effect of fluoride at plaque fluid concentrations on enamel de- and remineralisation at low pH. Caries Res 2006;40:522–529.
27.
Lynch RJM, Mony U, ten Cate JM: The effect of lesion characteristics and mineralising solution type on enamel remineralisation in vitro. Caries Res 2007;41:257–62.
28.
Lynch RJM, ten Cate JM: The effect of adjacent dentine blocks on the demineralisation and remineralisation of enamel in vitro. Caries Res 2006a;40:38–42.
29.
Lynch RJM, ten Cate JM: The effect of lesion characteristics at baseline on subsequent de- and remineralisation behaviour. Caries Res 2006b;40:530–535.
30.
Margolis HC, Varughese K, Moreno E: Effect of fluoride on crystal growth of calcium apatites in the presence of a salivary inhibitor. Calcif Tiss Int 1982;34:S33–S40.
31.
Özdemir A, Sayal A, Akca E, Aydin A: The determination of salivary zinc level following delivery from zinc-containing toothpaste. Tr J Med Sci 1998;28:281–283.
32.
Palamara J, Phakey PP, Rachinger WA, Orams HJ: Laminated zones in carious human dental enamel. J Oral Pathol 1986;15:109–114.
33.
Ripa LW, Leske GS, Triol CW, Volpe AR: Clinical study of the anticaries efficacy of three fluoride dentifrices containing anticalculus ingredients: three-year (final) results. J Clin Dent 1990;2:29–33.
34.
Rose RK: Competitive binding of calcium, magnesium and zinc to Streptococcus sanguis and purified S. sanguis cell walls. Caries Res 1996;30:71–75.
35.
Saxton CA, Harrap GJ, Lloyd AM: The effect of dentifrices containing zinc citrate on plaque growth and oral zinc levels. J Clin Periodontol 1986;13:301–306.
36.
Schäfer F, Adams SE, Nicholson JA, Cox TF, McGrady M, Moore F: In vivo evaluation of an oral health toothpaste with 0.1% vitamin E acetate and 0.5% sunflower oil (with vitamin F). Int Dent J 2007;57:119–123.
37.
Segreto VA, Collins EM, D’Agostino R, Cancro LM, Pfeifer HJ, Gilbert RJ: Anti-calculus effect of a dentifrice containing 0.5% zinc citrate dihydrate. Community Dent Oral Epidemiol 1991;19:29–31.
38.
Silverstone LM: The histopathology of early enamel caries in the enamel of primary teeth. J Dent Child 1970;37:17.
39.
Silverstone LM: Remineralization and enamel caries: new concepts. Dent Update 1983;10:261–273.
40.
Silverstone LM, Wefel JS, Zimmerman BF, Clarkson BH, Featherstone MJ: Remineralisation of natural and artificial lesions in human dental enamel in vitro. Caries Res 1981;15:138–157.
41.
Stephen KW, Creanor SL, Russell JI, Burchell CK, Huntington E, Downie CF: A 3-year oral health dose-response study of sodium monofluorophosphate dentifrices with and without zinc citrate: anti-caries results. Community Dent Oral Epidemiol 1988;16:321–325.
42.
Ten Cate JM: The caries-preventive effect of a fluoride dentifrice containing triclosan and zinc citrate, a compilation of in vitro and in situ studies. Int Dent J 1993;43:407–413.
43.
Ten Cate JM, Duijsters PP: Alternating demineralization and remineralization of artificial enamel lesions. Caries Res 1982;16:201–210.
44.
Ten Cate JM, Shariati M, Featherstone JDB: Enhancement of (salivary) remineralization by ‘dipping’ solutions. Caries Res 1985;19:335–341.
45.
Ten Cate JM, van Loveren C: Fluoride mechanisms. Dent Clin North Am 1999;43:713–742.
46.
Theuns HM: The Influence of in vivo and in vitro Demineralising Conditions on Dental Enamel; thesis, University of Nijmegen, 1987.
47.
Vogel GL, Mao Y, Chow LC, Proskin HM: Fluoride in plaque fluid, plaque, and saliva measured for 2 hours after a sodium fluoride monofluorophosphate rinse. Caries Res 2000;34:404–411.
48.
Young A, Jonski G, Rölla G: Inhibition of orally produced volatile sulfur compounds by zinc, chlorhexidine or cetylpyridinium chloride – effect of concentration. Eur J Oral Sci 2003;111:400–404.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.